European countries are looking at buying millions of COVID-19 rapid tests mostly from Roche and Abbott , an EU document shows, as global production of the tests is stretched by a surge in infections.

Surging COVID-19 cases globally will necessitate a shift to more testing with cheap, less-accurate antigen tests because more-accurate molecular, or PCR, tests are in short supply, the Swiss drugmaker ...

Everyone flirted with 89bio. Only Roche wanted to put a ring on it. In a financial filing, 89bio detailed the path from talks with numerous drugmakers to weeks of negotiations with Roche that ended in ...

Swiss healthcare major Roche Pharma is committing to invest 1.5 billion Swiss Franc in India over the next five years, a senior company executive said on Wednesday. Speaking at the India-European Free ...

Roche's Genentech unit has started work on a $700 million manufacturing facility in North Carolina, part of a promised $50 billion investment in the US. The plant – its first on the East Coast of the ...

The PCR Awards 2025 lit up The Brewery in London last night, honouring the brightest stars in the tech channel across retailers, resellers, distributors, vendors, support services, and sustainability.

ZURICH (Reuters) -Swiss companies Roche and Novartis on Friday flagged they did not expect to be hit by President Donald Trump's latest pharmaceutical tariff announcement because they are in the ...

pCR defined as no invasive and no in situ residuals in breast and nodes can best discriminate between patients with favorable and unfavorable outcomes. Patients with noninvasive or focal-invasive ...

Roche has staked a claim to use its oral selective oestrogen receptor degrader (SERD) giredestrant as a second-line therapy for breast cancer, regardless of a patient's ESR1 mutation status. Top-line ...

The Therapeutic Goods Administration (TGA) says 21 sunscreens that share the same base formulation have been recalled, paused or are under its review. The TGA says it has "significant concerns" about ...